Free tool
FAERS Monitor: Topamax Sprinkle
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020844 or its brand name (Topamax Sprinkle, Topiramate). Reports on generic versions are filed under their own applications.
Reports
92,148
Serious
64,116
70% of reports
Hospitalization
23,994
Death reported
7,028
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective10,548
- off label use7,681
- headache6,623
- nausea6,046
- fatigue5,536
- pain4,701
- migraine4,500
- dizziness4,290
- seizure3,887
- diarrhoea3,826
- vomiting3,773
- depression3,718
- product use in unapproved indication3,361
- weight increased3,140
- condition aggravated3,055
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,032 |
| 2005 | 1,462 |
| 2006 | 1,578 |
| 2007 | 1,391 |
| 2008 | 1,612 |
| 2009 | 2,237 |
| 2010 | 2,824 |
| 2011 | 3,117 |
| 2012 | 3,489 |
| 2013 | 3,185 |
| 2014 | 3,698 |
| 2015 | 5,908 |
| 2016 | 6,576 |
| 2017 | 5,198 |
| 2018 | 6,041 |
| 2019 | 6,491 |
| 2020 | 5,713 |
| 2021 | 5,342 |
| 2022 | 5,096 |
| 2023 | 5,154 |
| 2024 | 5,748 |
| 2025 | 5,583 |
| 2026 | 3,668 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,962,011 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| migraineSignal | 4,500 | 11.2 | 10.9 | 40,184 |
| seizureSignal | 3,887 | 7.9 | 7.7 | 22,806 |
| depressionSignal | 3,718 | 3.8 | 3.7 | 7,540 |
| weight increasedSignal | 3,140 | 3.2 | 3.1 | 4,820 |
| product use in unapproved indicationSignal | 3,361 | 3.1 | 3.0 | 4,843 |
| headacheSignal | 6,623 | 2.4 | 2.4 | 5,661 |
| condition aggravatedSignal | 3,055 | 2.3 | 2.2 | 2,270 |
| off label useSignal | 7,681 | 2.0 | 2.0 | 4,037 |
| dizziness | 4,290 | 2.0 | 1.9 | 2,085 |
| vomiting | 3,773 | 1.8 | 1.8 | 1,463 |
| drug ineffective | 10,548 | 1.8 | 1.8 | 4,229 |
| pain | 4,701 | 1.8 | 1.7 | 1,552 |
| nausea | 6,046 | 1.7 | 1.7 | 2,000 |
| fatigue | 5,536 | 1.6 | 1.6 | 1,380 |
| diarrhoea | 3,826 | 1.4 | 1.3 | 365 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.